About
Technology
Issues
FAQ
Links
Official Page
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.